Central Trust Company’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $275K | Sell |
939
-105
| -10% | -$34.5K | 0.01% | 532 |
|
|
2025
Q4 | $366K | Sell |
1,044
-470
| -31% | -$159K | 0.01% | 483 |
|
|
2025
Q3 | $489K | Sell |
1,514
-214
| -12% | -$66.6K | 0.01% | 429 |
|
|
2025
Q2 | $672K | Buy |
1,728
+46
| +3% | +$18.5K | 0.02% | 378 |
|
|
2025
Q1 | $732K | Sell |
1,682
-44
| -3% | -$17.7K | 0.02% | 363 |
|
|
2024
Q4 | $637K | Buy |
1,726
+195
| +13% | +$81.6K | 0.02% | 378 |
|
|
2024
Q3 | $796K | Sell |
1,531
-819
| -35% | -$438K | 0.02% | 355 |
|
|
2024
Q2 | $1.27M | Buy |
2,350
+53
| +2% | +$28K | 0.03% | 287 |
|
|
2024
Q1 | $1.19M | Buy |
2,297
+34
| +2% | +$16.9K | 0.03% | 306 |
|
|
2023
Q4 | $1.07M | Hold |
2,263
| – | – | 0.03% | 308 |
|
|
2023
Q3 | $985K | Sell |
2,263
-208
| -8% | -$94.3K | 0.03% | 317 |
|
|
2023
Q2 | $1.1M | Buy |
2,471
+940
| +61% | +$434K | 0.03% | 302 |
|
|
2023
Q1 | $704K | Sell |
1,531
-1,305
| -46% | -$621K | 0.02% | 354 |
|
|
2022
Q4 | $1.45M | Sell |
2,836
-41
| -1% | -$20.8K | 0.04% | 247 |
|
|
2022
Q3 | $1.31M | Sell |
2,877
-15
| -0.5% | -$7.18K | 0.04% | 256 |
|
|
2022
Q2 | $1.4M | Sell |
2,892
-35
| -1% | -$17.3K | 0.05% | 262 |
|
|
2022
Q1 | $1.44M | Buy |
2,927
+29
| +1% | +$13.3K | 0.04% | 272 |
|
|
2021
Q4 | $1.34M | Hold |
2,898
| – | – | 0.04% | 295 |
|
|
2021
Q3 | $1.08M | Sell |
2,898
-17
| -0.6% | -$6.46K | 0.04% | 303 |
|
|
2021
Q2 | $1.11M | Sell |
2,915
-139
| -5% | -$53.1K | 0.04% | 294 |
|
|
2021
Q1 | $1.1M | Sell |
3,054
-62
| -2% | -$19.9K | 0.04% | 280 |
|
|
2020
Q4 | $1M | Buy |
3,116
+42
| +1% | +$12.9K | 0.04% | 279 |
|
|
2020
Q3 | $826K | Buy |
3,074
+83
| +3% | +$22.3K | 0.04% | 275 |
|
|
2020
Q2 | $787K | Buy |
2,991
+60
| +2% | +$16K | 0.04% | 268 |
|
|
2020
Q1 | $666K | Buy |
2,931
+250
| +9% | +$68.1K | 0.04% | 278 |
|
|
2019
Q4 | $809K | Sell |
2,681
-123
| -4% | -$33.8K | 0.04% | 286 |
|
|
2019
Q3 | $673K | Sell |
2,804
-87
| -3% | -$23.8K | 0.04% | 298 |
|
|
2019
Q2 | $879K | Buy |
2,891
+91
| +3% | +$24.9K | 0.05% | 255 |
|
|
2019
Q1 | $804K | Sell |
2,800
-45
| -2% | -$13K | 0.05% | 262 |
|
|
2018
Q4 | $747K | Buy |
2,845
+90
| +3% | +$24.7K | 0.05% | 257 |
|
|
2018
Q3 | $755K | Sell |
2,755
-2,800
| -50% | -$727K | 0.04% | 276 |
|
|
2018
Q2 | $1.32M | Buy |
5,555
+83
| +2% | +$19.2K | 0.08% | 203 |
|
|
2018
Q1 | $1.2M | Hold |
5,472
| – | – | 0.08% | 215 |
|
|
2017
Q4 | $1.23M | Hold |
5,472
| – | – | 0.08% | 218 |
|
|
2017
Q3 | $1.04M | Sell |
5,472
-126
| -2% | -$24K | 0.07% | 230 |
|
|
2017
Q2 | $1.05M | Buy |
5,598
+381
| +7% | +$68.5K | 0.07% | 227 |
|
|
2017
Q1 | $863K | Sell |
5,217
-42
| -0.8% | -$6.68K | 0.06% | 246 |
|
|
2016
Q4 | $756K | Buy |
5,259
+376
| +8% | +$50.3K | 0.05% | 257 |
|
|
2016
Q3 | $611K | Buy |
4,883
+76
| +2% | +$9.81K | 0.04% | 269 |
|
|
2016
Q2 | $632K | Buy |
4,807
+160
| +3% | +$21.9K | 0.05% | 271 |
|
|
2016
Q1 | $646K | Hold |
4,647
| – | – | 0.05% | 264 |
|
|
2015
Q4 | $648K | Buy |
4,647
+45
| +1% | +$6.2K | 0.05% | 254 |
|
|
2015
Q3 | $644K | Buy |
4,602
+45
| +1% | +$6.76K | 0.06% | 251 |
|
|
2015
Q2 | $748K | Hold |
4,557
| – | – | 0.06% | 248 |
|
|
2015
Q1 | $704K | Hold |
4,557
| – | – | 0.06% | 247 |
|
|
2014
Q4 | $573K | Sell |
4,557
-102
| -2% | -$12.6K | 0.05% | 274 |
|
|
2014
Q3 | $557K | Hold |
4,659
| – | – | 0.04% | 281 |
|
|
2014
Q2 | $502K | Buy |
4,659
+200
| +4% | +$20.6K | 0.04% | 308 |
|
|
2014
Q1 | $444K | Buy |
4,459
+275
| +7% | +$24.9K | 0.04% | 314 |
|
|
2013
Q4 | $387K | Hold |
4,184
| – | – | 0.03% | 330 |
|
|
2013
Q3 | $350K | Buy |
4,184
+156
| +4% | +$13.4K | 0.03% | 331 |
|
|
2013
Q2 | $330K | Buy |
+4,028
| New | +$301K | 0.03% | 320 |
|
Other funds holding ELV
VCM
VPM
Central Trust Company's ELV Position: Q1 2026 in Review
Central Trust Company reduced its Elevance Health (ELV) stake by 10% in Q1 2026, selling an estimated $34.5K and leaving 939 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #532.
Central Trust Company first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.45M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Central Trust Company held 939 shares of Elevance Health worth $275K as of Q1 2026.
- Central Trust Company sold 105 Elevance Health shares in Q1 2026, an estimated $34.5K.
- Elevance Health made up 0.01% of Central Trust Company's portfolio in Q1 2026, its #532 holding.
- Central Trust Company first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Central Trust Company's Elevance Health position peaked at $1.45M in Q4 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.